product
What the medicine is
medicineIdentity`: product name, classification codes, holder reference · `activeComposition`: active substances with roles and reference strengths · `formAndStrength`: dose forms, strengths, routes of administration
This meta-model describes medicinal products and controlled substances: what a medicine contains and in what form and strength, under which authorizations and schedules it may circulate, how its batches move, and what safety signals surround it. It is its own model because medicines combine market goods semantics with a dense regulatory and vigilance apparatus (authorizations, controlled status, batch verification, signals) that no other goods category carries.
What the medicine is
medicineIdentity`: product name, classification codes, holder reference · `activeComposition`: active substances with roles and reference strengths · `formAndStrength`: dose forms, strengths, routes of administration
Under what permissions it circulates
marketingAuthorization`: authorizations per jurisdiction with status and conditions · `controlledStatus`: scheduling of the product or its substances per jurisdiction
How physical product reaches use
batchAndSerialization`: batches, expiry, pack serialization ranges · `supplyStatus`: availability and shortage standing per market
What safety knowledge surrounds it
safetySignal`: signals, their sources, assessment state and outcomes
Catalogue-native findings must describe the information grouped by each layer. This legacy version does not declare them separately.
Questions, artifact requirements and serial naming rules are required by Vercy vNext; they remain unassigned in this reference version.
Format-independent core. Concrete artifact formats and naming prefixes are not declared in this legacy version.
CRUD procedures and interface bindings are not declared in this legacy version.
Product records are stewarded by the producer holding the marketing authorization, while authorization, scheduling and vigilance layers are overseen by a public health authority archetype; in both cases access by any other party is granted by the record owner through S1/S2, and all regulatory events are traceable via S4 audit.